Detection of scarred and viable myocardium using a new magnetic resonance imaging technique: Blood oxygen level dependent (BOLD) MRI

Heart

Volumn 89, Issue 7, 2003, Pages 738-744

  Egred, Mohaned ^a   Al Mohammad, A ^b   Waiter, G D ^c   Redpath, T W ^c   Semple, S K ^c   Norton, M ^c   Welch, A ^c   Walton, S ^d  

^a UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

^b NORTHERN GENERAL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPYRIDAMOLE; OXYGEN;

ADULT; AGED; ARTICLE; BREATH HOLDING; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAM; FEMALE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE; HEART VENTRICLE WALL; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN BLOOD LEVEL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REST; STRESS;

EID: 0038207171     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.89.7.738     Document Type: Article

References (50)

1. Rahimtoola SH. The hibernating myocardium. Am Heart J 1989;117:211-21.
2. Rahimtoola SH. The hibernating myocardium in ischaemia and congestive heart failure. Eur Heart J 1993;14:212-20.
3. Ferrari R, La Canna G, Guibbini R, et al. Hibernating myocardium in patients with coronary artery disease: identification and clinical importance. Cardiovasc Drugs Ther 1992;6:287-93.
4. Ferrari R, La Canna G, Guibbini R, et al. Left ventricular dysfunction due to stunning and hibernation in patients. Cardiovasc Drugs Ther 1994;8:371-80.
5. Rahimtoola SH. Coronary bypass surgery for angina - 1981: a perspective. Circulation 1982;65:225-41.
6. Braunwald E, Rutherford JD. Reversible ischaemic left ventricular dysfunction: evidence for the "hibernating myocardium." J Am Coll Cardiol 1986;8:1467-70.
7. Eitzman D, Al-Aouar Z, Kanter HL, et al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. Am J Cardiol 1992;20:559-65.
8. Di Carli MF, Davidson M, Little R, et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994;73:527-33.
9. Lee KS, Marwick TH, Cook SA, et al. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction: relative efficacy of medical therapy and revascularisation. Circulation 1994;90:2687-94.
10. Dilsizian V, Bonow RO. Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation 1993;87:1-20.
11. Arnese M, Cornel JH, Salustri A, et al. Prediction of regional left ventricular function after surgical revascularisation. Circulation 1995;91:2748-52.
12. Atalay MK, Reeder SB, Zerhouni EA, et al. Blood oxygenation dependence of T1 and T2 in the isolated, perfused rabbit heart at 4.7 T. Magn Reson Med 1995;34:623-7.
13. Janick PA, Hacheney DB, Grossmann RI, et al. MR imaging of various oxidation states of intracellular and extracellular hemoglobin. Am J Neuroradiol 1991;12:891-7.
14. Niemi P, Poncelet B, Kwong K, et al. Myocardial intensity changes associated with flow stimulation in blood oxygenation sensitive magnetic resonance imaging. Magn Reson Med 1996;36:78-82.
15. Waker C, Bock M, Hartlep A. BOLD MRI in ten patients with coronary artery disease: evidence for imaging of capillary recruitment in myocardium supplied by the stenotic artery. MAGMA 1999;8:48-54.
16. Wacker C, Hartlep A, Bock M. BOLD MRI in patients with coronary artery disease: another step to a "one-stop shop" in cardiology? [abstract]. Proc Int Soc Magn Reson Med 1999;1:308.
17. Friedrich M, Niendorf T, Schulz-Menger J. Blood oxygen level dependent (BOLD) MRI in patients with symptoms of coronary artery disease [abstract]. Proc Int Soc Magn Reson Med 2000;2:1567.
18. Bauer W, Nadler W, Bock M. Theory of the BOLD effect in the capillary region: an analytical approach for the determination of T2* in the capillary network of myocardium. Magn Reson Med 1999;41:51-62.
19. Wacker C, Bock M, Hartlep. Change in myocardial oxygenation and perfusion under pharmacological stress with dipyridamole: assessment using T2* and T1 measurements. Magn Reson Med 1999;41:686-95.
20. Bauer W, Nadler W, Bock M. The relation between the BOLD-induced T2 and T2*: a theoretical approach for the vasculature of myocardium. Magn Resort Med 1999;42:1004-10.
21. Li D, Dhawale P, Rubin P. Myocardial signal response to dipyridamole and dobutamine: demonstration of the BOLD effect using a double-echo gradient-echo sequence. Magn Reson Med 1996;36:16-20.
22. Chan RK, Lee KJ, Calafiore P, et al. Comparison of dobutamine echocardiography and positron emission tomography in patients with chronic ischemic left ventricular dysfunction. J Am Coll Cardiol 1996;27:1601-7.
23. Schelbert HR, Phelps ME, Huang SC, et al. N-13 ammonia as an indicator of myocardial blood flow. Circulation 1981;63:1259-72.
24. Hutchins GD, Schwaiger M, Rosenspire KC, et al. Non-invasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol 1990;15:1032-42.
25. Schelbert HR, Phelps ME, Hoffman EJ, et al. Regional myocardial perfusion assessed with N-13 labelled ammonia and positron emission computerised axial tomography. Am J Cardiol 1979;43:209-18.
26. 13NH3 by the myocardium on metabolic factors and its implications for quantitative assessment of perfusion. Circulation 1980;61:34-43.
27. Vom Dahl J, Eitzman DT, Al-Aouar ZR, et al. Relation of regional function, perfusion, and metabolism in patients with advanced coronary artery disease undergoing surgical revascularisation. Circulation 1994;90:2356-66.
28. Georg Wolpers H, Burchert W, van den Hoff J, et al. Assessment of myocardial viability by use of 11C-acetate and positron emission tomography, threshold criteria of reversible dysfunction. Circulation 1997;95:1417-24.
29. Bendel P. Snapshot MRI with T2*-weighted magnetisation preparation. Magn Reson Med 1993;30:399-402.
30. Semple SIK, Redpath TW, Waiter GD, et al. A novel T2*-weighted snapshot FLASH preparation and its implementation for cardiac imaging. Proc Int Soc Magn Reson Imaging 2003;2:1717.
31. Al-Mohammad A, Mahy IR, Norton MY, et al. Prevalence of hibernating myocardium in patients with severely impaired ischemic left ventricles. Heart 1998;80:559-64.
32. Goris ML, Thomson C, Malone LJ, et al. Modelling the integration of myocardial regional perfusion and function. Nucl Med Commun 1994;15:9-20
33. Adams JN, Norton M, Trent RJ, et al. Incidence of hibernating myocardium after acute myocardial infarction treated with thrombolysis. Heart 1996;75:442-6.
34. 18F-labeled fluorodeoxyglucose and N-13 ammonia. Circulation 1983;67:766-88.
35. Tillisch JH, Brunken R, Marshall R, et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 1986;314:884-8.
36. Brunken R, Tillisch J, Schwaiger M, et al. Regional perfusion, glucose metabolism, and wall motion in patients with chronic elactrocardiographic Q wave infarctions: evidence for persistence of viable tissue in some infarct regions by positron emission tomography. Circulation 1986;73:951-63.
37. Schelbert HR, Buxton D. Insight into coronary artery disease gained from metabolic imaging. Circulation 1988;78:496-505.
38. Fudo T, Kambara H, Hashimoto T, et al. F-18 deoxyglucose and stress N-13 ammonia positron emission tomography in anterior wall healed myocardial infarction. Am J Cardiol 1988;61:1191-7.
39. Waiter G, McKiddie FI, Redpath TW, et al. Determination of normal regional left ventricular function from cine-MR images using a semi-automated edge detection method. Magn Reson Imaging 1999;17:99-107.
40. Van der Wall E, Vliegen H, de Roos A, et al. Magnetic resonance imaging in coronary artery disease. Circulation 1995;92:2723-39.
41. 99mTc-methoxyisobutyl-isonitrile SPECT. Am Heart J 1992;123:636-45.
42. 201TI in patients with chronic coronary artery disease and left ventricular dysfunction. Circulation 1992;86:1125-37.
43. Wu E, Judd R, Vargas J, et al. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 2001;357:21-8.
44. Kim R J, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-53.
45. Engtelstad BL, Wolf GL. Contrast agents. In: Stark DD, Bradley WG, eds. Magnetic resonance imaging. St Louis: CV Mosby, 1988:161-81.
46. Epstein FH, Wolff SD, Arai AE. Segmented k-space fast cardiac imaging using an echo-train readout. Magn Reson Med 1999;41:609-13.
47. Sodickson DR, Manning WJ. Simultaneous acquisition of spatial harmonics (SMASH): fat imaging with radiofrequency coil arrays. Magn Reson Med 1997;38:591-603.
48. Pruessman KP, Weiger M, Scheidegger MB, et al. SENSE: sensitivity encoding for fast MRI. Magn Reson Med 1999;42:952-62.
49. Tamaki N, Kawamoto M, Tadamura E, et al. Prediction of reversible ischemia after revasculansation: perfusion and metabolic studies with positron emission tomography. Circulation 1995;91:1697-705.
50. Gati JS, Menon SM, Ugurbil K, et al. Experimental determination of the BOLD field strength dependence in vessels and tissue. Magn Reson Med 1997;38:296-302.